🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of the Chi...
Status
Completed
Location
Longhua hospital
Start Date
2009-08
Trial ID
NCT00963287
Treatments Being Tested
The purpose of this study is to explore the pathogenesis of cognitive impai...
Status
Unknown
Location
Department of Neurology,Dongfang Hospital,Beijing University of Chinese Medicine
Start Date
2016-12
Trial ID
NCT02752867
Treatments Being Tested
The incidence of cardiovascular disease is still high in China under the co...
Status
Not Yet Recruiting
Location
Xiaolu Li
Start Date
2022-08-01
Trial ID
NCT05466968
Treatments Being Tested
In order to reduce the clinical demand for kidney dialysis rate of Diabetic...
Status
Not Yet Recruiting
Location
Dongzhimen Hospital of BeijingUniversity of Chinese Medicine
Start Date
2025-08-01
Trial ID
NCT07032116
To clarify the changes of intestinal flora - gut - brain axis in FGIDs pati...
Status
Unknown
Location
Xiyuan Hospital of China Academy of Chinese Medical Science
Start Date
2020-06-25
Trial ID
NCT04454996
The purpose of this study is to evaluate efficacy of Chinese medicine treat...
Status
Completed
Location
Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
Start Date
2018-03-12
Trial ID
NCT02955134
Treatments Being Tested
In the early stage, the preliminary study found that traditional Chinese me...
Status
Unknown
Location
Multiple Locations
Start Date
2021-06-15
Trial ID
NCT04935073
Hepatic encephalopathy is the most common complication after TIPS, and hepa...
Status
Unknown
Location
he First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
Start Date
2021-12-01
Trial ID
NCT05128305
Treatments Being Tested
Approximately 60% and 90% of patients with head and neck (H\&N) cancers rec...
Status
Unknown
Location
Hong Kong Institute of Integrative Medicine
Start Date
2023-01-31
Trial ID
NCT05664906
Treatments Being Tested
Pyrotinib is an important drug for the treatment of breast cancer, but the ...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-10-08
Trial ID
NCT04988165
Treatments Being Tested